Noninvasive detection for UC tumor markers, such as ELISA analysis of nuclear matrix protein 22 (NMP22) and/or bladder tumor antigen (BTA),4, 5 have been clinically implemented. The gene discussed is NUMA1; the disease is neoplasm.